NACDS President and CEO Steven C. Anderson discussed the importance of strong leadership in times of crisis with Dr. Peter Cressy, Director of the prestigious George Washington Leadership Institute of The George Washington Presidential Library at Mount Vernon.
National organization representing pharmacies of diverse formats and sizes says: “By any measure, America’s pharmacies present patients and the nation with an efficient, effective and essential component of vaccine deployment”
The discussion addressed the question: “Once the COVID-19 vaccine is available, how do we immunize the American people the fastest way possible so we can open all aspects of the U.S. economy?”
Letter to National Governors Association leaders and all governors stresses the importance of establishing certainty that flexibilities established early in the pandemic will be sustained.
NACDS issues an open letter to Congress urging a necessary step to help scale and sustain COVID-19 testing.
Chain Drug Review published NACDS President & CEO Steven C. Anderson's report on NACDS' COVID-19 advocacy.
The NACDS Board of Directors on July 8 held a “virtual” meeting with Department of Health and Human Services Assistant Secretary for Health ADM Brett P. Giroir, M.D.
NACDS, national pharmacy groups request clarity from HHS surrounding pharmacists’ vaccination authority under the PREP Act.
On June 24, the NACDS Board of Directors “virtually” met with eight key members of the Administration and Congress.
FMI, NACDS, NCPA, NGA, and PCMA today issued the following joint statement outlining the best practices for pharmacies and PBMs to follow for documenting signature-free delivery or pick-up of prescription drugs during the Public Health Emergency related to the COVID-19 pandemic.
